Efficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Old

dc.contributor.authorEskiyurt, Nurten
dc.contributor.authorGunaydin, Rezzan
dc.contributor.authorErhan, Belgin
dc.contributor.authorBodur, Hatice
dc.contributor.authorKirnap, Mehmet
dc.contributor.authorSepici, Vesile
dc.contributor.authorKuran, Banu
dc.date.accessioned2024-02-23T14:45:22Z
dc.date.available2024-02-23T14:45:22Z
dc.date.issued2013
dc.departmentNEÜen_US
dc.descriptionAnnual Meeting of the American-Society-for-Bone-and-Mineral-Research -- OCT 04-07, 2013 -- Baltimore, MDen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.description.sponsorshipAmer Soc Bone & Mineral Resen_US
dc.identifier.issn0884-0431
dc.identifier.issn1523-4681
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17393
dc.identifier.volume28en_US
dc.identifier.wosWOS:000332035804002en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofJournal Of Bone And Mineral Researchen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleEfficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Olden_US
dc.typeConference Objecten_US

Dosyalar